PCM
Polaris Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.3M | Sell |
634,160
-245,000
| -28% | -$26M | 4.48% | 5 |
|
|
2025
Q1 | $109M | Sell |
879,160
-206,700
| -19% | -$25.7M | 6.24% | 5 |
|
|
2024
Q4 | $134M | Sell |
1,085,860
-219,700
| -17% | -$27.1M | 6.45% | 4 |
|
|
2024
Q3 | $145M | Sell |
1,305,560
-69,900
| -5% | -$7.79M | 7.17% | 3 |
|
|
2024
Q2 | $147M | Sell |
1,375,460
-57,200
| -4% | -$6.1M | 7.87% | 3 |
|
|
2024
Q1 | $173M | Buy |
1,432,660
+165,200
| +13% | +$19.9M | 8.6% | 3 |
|
|
2023
Q4 | $156M | Buy |
1,267,460
+27,100
| +2% | +$3.33M | 7.53% | 3 |
|
|
2023
Q3 | $161M | Sell |
1,240,360
-56,300
| -4% | -$7.29M | 8.65% | 2 |
|
|
2023
Q2 | $161M | Sell |
1,296,660
-11,200
| -0.9% | -$1.39M | 6.04% | 2 |
|
|
2023
Q1 | $191M | Buy |
1,307,860
+54,500
| +4% | +$7.97M | 7.14% | 2 |
|
|
2022
Q4 | $200M | Sell |
1,253,360
-217,100
| -15% | -$34.6M | 6.95% | 2 |
|
|
2022
Q3 | $196M | Sell |
1,470,460
-7,800
| -0.5% | -$1.04M | 7.69% | 2 |
|
|
2022
Q2 | $231M | Sell |
1,478,260
-25,700
| -2% | -$4.01M | 8.24% | 2 |
|
|
2022
Q1 | $234M | Sell |
1,503,960
-8,500
| -0.6% | -$1.32M | 7.44% | 2 |
|
|
2021
Q4 | $193M | Sell |
1,512,460
-450,303
| -23% | -$57.4M | 6.21% | 4 |
|
|
2021
Q3 | $256M | Buy |
1,962,763
+670,003
| +52% | +$87.2M | 8.15% | 2 |
|
|
2021
Q2 | $230M | Buy |
+1,292,760
| New | +$230M | 7.41% | 2 |
|